(1R)-1-phenyl-N,N-bis[(1R)-1-phenylethyl]ethanamine;(1S)-1-phenyl-N,N-bis[(1S)-1-phenylethyl]ethanamine
C48H54N2 — CID 139197887
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1R)-1-phenyl-N,N-bis[(1R)-1-phenylethyl]ethanamine;(1S)-1-phenyl-N,N-bis[(1S)-1-phenylethyl]ethanamine
(1R)-1-phenyl-N,N-bis[(1R)-1-phenylethyl]ethanamine;(1S)-1-phenyl-N,N-bis[(1S)-1-phenylethyl]ethanamine (PubChem CID 139197887) has the molecular formula C48H54N2 and a molecular weight of 658.97 g/mol. Its IUPAC name is (1R)-1-phenyl-N,N-bis[(1R)-1-phenylethyl]ethanamine;(1S)-1-phenyl-N,N-bis[(1S)-1-phenylethyl]ethanamine.
Molecular Properties
| Compound Name | (1R)-1-phenyl-N,N-bis[(1R)-1-phenylethyl]ethanamine;(1S)-1-phenyl-N,N-bis[(1S)-1-phenylethyl]ethanamine |
|---|---|
| PubChem CID | 139197887 |
| Molecular Formula | C48H54N2 |
| Molecular Weight | 658.97 g/mol |
| Exact Mass | 658.43 |
| IUPAC Name | (1R)-1-phenyl-N,N-bis[(1R)-1-phenylethyl]ethanamine;(1S)-1-phenyl-N,N-bis[(1S)-1-phenylethyl]ethanamine |
| SMILES | C[C@@H](c1ccccc1)N([C@@H](C)c1ccccc1)[C@@H](C)c1ccccc1.C[C@H](c1ccccc1)N([C@H](C)c1ccccc1)[C@H](C)c1ccccc1 |
| InChI | InChI=1S/2C24H27N/c2*1-19(22-13-7-4-8-14-22)25(20(2)23-15-9-5-10-16-23)21(3)24-17-11-6-12-18-24/h2*4-21H,1-3H3/t2*19-,20-,21-/m10/s1 |
| InChIKey | UMSLVWGFIJZYCE-BAGSRVKRSA-N |
| XLogP | 13.14 |
| TPSA | 6.48 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 658.97 |
| LogP ≤ 5 | 13.14 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139197887 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.